News & Events

• April 27, 2015
  

  Critical Path Institute Secures Regulatory Support For Parkinson’s And Alzheimer’s Disease Biomarkers​

  April 27, 2015 Critical Path Institute Secures Regulatory Support For Parkinson’s And Alzheimer’s Disease Biomarkers FDA Endorses Biomarkers for Use in Early Stages of Brain Disease TUCSON, Ariz., April 27, 2015 — Critical Path Institute (C-Path) announced that the U.S. Food and Drug Administration (FDA) has issued three Letters of Support to C-Path’s Coalition Against...
• April 23, 2015
  

  The TREAT-NMD Advisory Committee for Therapeutics (TACT): An Innovative de-Risking Model to Foster Orphan Drug Development

• April 21, 2015
  

  CAMD: Development of Therapeutic Area-Specific Data Standards for Brain Diseases

• April 20, 2015
  

  C-Path featured in the April 16 newsletter of the Multi-Regional Clinical Trials Center at Harvard

• April 14, 2015
  

  Bring Your Own Device (BYOD): The Collection Of Electronic Patient-Reported Outcome Data